It’ll be distributed by Nordisk Film Distribution, and is currently seeking additional funding. No further cast members have been announced yet. In 2020, NME praised Ulven’s early “self ...

Days before the Oscar race officially kicks off, one of the expected front-runners sparked controversy when the film's editor admitted using artificial intelligence to enhance Hungarian accents in ...

The actress is reportedly in the city to participate in a grand announcement for RRR director SS Rajamouli's upcoming film, starring Mahesh Babu. On Tuesday, Priyanka shared pictures from her ...

On Tuesday, BofA Securities expressed continued confidence in Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), maintaining a Buy rating and a price target of DKK1,075.00. The endorsement comes amidst ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

The Monkey will be released in cinemas on February 21, but audiences at Beyond Fest were treated to an early screening of the ‘sadistic’ and ‘gory’ horror film. Taking to social media ...

Bernard Arnault is once again in charge of Europe's most valuable company. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK875.00. The company’s shares closed ...

El 47 (“the 47”) triumphed at the Catalan Film Awards Saturday evening, taking eight prizes including one for Best Picture. The film previously won two Forqué Awards and has 14 nominations ...

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

Novo Nordisk (NVO) announced Friday that its popular obesity therapy, semaglutide, marketed as Wegovy, led to 20.7% weight loss over 72 weeks at a higher dose of 7.2 mg in a late-stage trial.